BONFANTI, PAOLO

BONFANTI, PAOLO  

DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)  

Mostra records
Risultati 1 - 20 di 313 (tempo di esecuzione: 0.028 secondi).
Titolo Tipologia Data di pubblicazione Autori File
Awake Prone Positioning in Adults With COVID-19: An Individual Participant Data Meta-Analysis 01 - Articolo su rivista 2025 Lapadula, GiuseppeBonfanti, Paolo +
Brief Report: New HIV Diagnoses in PrEP-Experienced and PrEP-Naive Persons in the ICONA Cohort 01 - Articolo su rivista 2025 Puoti M.Bonfanti PLapadula G. +
Ceftazidime-avibactam plus aztreonam versus cefiderocol in the treatment of infections caused by Metallo-β lactamase-Producing Microorganisms: real-word data from the Italian cohort SUSANA 02 - Intervento a convegno 2025 Mezzadri LCorti NBonfanti P. +
Challenges and opportunities for hepatitis B virus screening in people attending PrEP services: a retrospective prevalence study 01 - Articolo su rivista 2025 Monti, BiancaD'Aloia, FabianaPuoti, MassimoBonfanti, Paolo +
Comparison of meropenem-vaborbactam vs ceftazidime-avibactam in the treatment of KPC producing Klebsiella pneumoniae infections 02 - Intervento a convegno 2025 Mezzadri LCorti NBonfanti P. +
Effectiveness of dolutegravir-based vs boosted darunavir-based first-line 3-drug regimens in people with HIV with advanced disease: a trial emulation 01 - Articolo su rivista 2025 Bonfanti, P +
Impact of cefiderocol therapy on patient survival across different multi drug-resistant Gram-negative bacilli infections: insights from the SUSANA cohort 02 - Intervento a convegno 2025 Corti NBonfanti P. +
Impact of smoking habits on cardiovascular and neoplastic events and all-cause death in people living with HIVfrom the STOPSHIV cohort 01 - Articolo su rivista 2025 Bonfanti, Paolo +
Increased Pneumonia-Related Emergency Department Visits, Northern Italy 01 - Articolo su rivista 2025 Bonfanti, Paolo +
Inflammatory response in a patient with disseminated BCG infection: a diagnostic challenge 02 - Intervento a convegno 2025 Brogna VBonfanti P. +
Long-term durability of dolutegravir plus darunavir/cobicistat dual regimen in highly antiretroviral-experienced people with HIV (DoDaco study) 01 - Articolo su rivista 2025 Lapadula, GiuseppeMezzadri, LucaBonfanti, Paolo +
Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levels 01 - Articolo su rivista 2025 Biondi, AndreaBettini, Laura RacheleD'Angio, MariellaBonfanti, Paolo +
Remission of low-grade lymphomatoid granulomatosis with extensive pulmonary involvement following immune restoration via antiretroviral therapy in a newly diagnosed HIV patient 01 - Articolo su rivista 2025 Kogan, MariaAlviano, Antonio MariaCatalano, MartinaCasiraghi, AlessandraGhilardi, GiuliaRindone, GiovanniVerga, LuisaL'Imperio, VincenzoPasserini, Carlo GambacortiBonfanti, PaoloLapadula, GiuseppeCocito, FedericaSoria, Alessandro
Surge of Mpox cases in Lombardy region, Italy, October 2023 - January 2024 01 - Articolo su rivista 2025 Venturelli, SerenaBonfanti, PaoloBruno, RaffaeleRizzi, MarcoPuoti, Massimo +
Transaminase Decrease Upon Switch From TDF to TAF in PWH Is Modulated by HBV Status 02 - Intervento a convegno 2025 Lapadula GBonfanti P. +
Anti-spike antibody level is associated with the risk of clinical progression among subjects hospitalized with COVID-19 pneumonia: results from a retrospective cohort study 01 - Articolo su rivista 2024 Lapadula, GiuseppeMezzadri, LucaAntolini, LauraBonfanti, Paolo +
Cabotegravir-rilpivirine long-acting injectable regimen: an analysis of the causes of interruption and impact of genotypic drug resistance in a multicentric cohort 02 - Intervento a convegno 2024 Paolo Bonfanti +
Cabotegravir-rilpivirine long-acting injectable regimen: an analysis of the causes of interruption and impact of genotypic drug resistance in a multicentric cohort 02 - Intervento a convegno 2024 Bonfanti, P +
Caratterizzazione delle donne di nazionalità non italiana in una coorte geriatrica di persone che vivono con HIV 02 - Intervento a convegno 2024 Bonfanti Paolo +
Causes of discontinuation of long-acting cabotegravir and rilpivirine in clinical practice: results from the prospective multicentre SCOLTA cohort 02 - Intervento a convegno 2024 Paolo Bonfanti +